首页> 外文会议>Conference on Biomedical Thermoacoustics, Optoacoustics, and Acousto-optics; 20080120-23; San Jose,CA(US) >In vivo Photoacoustic Imaging with Multiple Selective Targeting Using Bioconjugated Gold Nanorods
【24h】

In vivo Photoacoustic Imaging with Multiple Selective Targeting Using Bioconjugated Gold Nanorods

机译:使用生物共轭金纳米棒具有多个选择性靶向的体内光声成像。

获取原文
获取原文并翻译 | 示例

摘要

In this study, photoacoustic imaging is utilized to probe information from oncogene surface molecules of cancer cell with the aid of specific targeting. The ultimate goal is to provide prediction of clinical outcome and treatment response of anti-cancer drugs. Different from single targeting in most research, we accomplished multiple targeting to obtain a molecular profile potentially representing tumor characteristics or to locate the heterogeneous population in one lesion. By conjugating different antibodies to gold nanorods corresponding to different peak absorption bands, multiple targeting and simultaneous detection with photoacoustic imaging can be achieved with laser irradiation at the respective peak optical absorption wavelength. Her2 and EGFR were chosen as our primary target molecules. The targeting complex was evaluated in two types of oral cancer cells, OECM1 and Cal27. The OECM1 cell line overexpresses Her2 but has low expression of EGFR, while Cal27 cell line expresses both antibodies. Also, the targeting efficacy to OECM1 can be further improved by using mixed nanoprobes. The cancer cells were induced on the back of the mice by subcutaneous injection. The captured images show that both cancer cells exhibit a higher photoacoustic response (maximum 3 dB) than control groups with specific targeting, thus demonstrating the feasibility of multiple selective targeting with bioconjugated gold nanorods. Images of multiple targeting with mixed nanoprobes of OECM1 cells also reveal further enhancement of targeting (4 dB). The results showed potential of in vivo photoacoustic molecular imaging, providing a better guidance for diagnosis and treatment of cancer.
机译:在这项研究中,利用光声成像技术借助特异性靶向来探测癌细胞癌基因表面分子的信息。最终目标是提供抗癌药物的临床结果和治疗反应的预测。与大多数研究中的单一靶向不同,我们完成了多重靶向以获得可能代表肿瘤特征的分子谱或在一个病变中定位异质群体。通过将不同的抗体与对应于不同峰吸收带的金纳米棒缀合,可以在相应的峰光吸收波长处进行激光照射,从而实现多目标定位和光声成像同时检测。选择Her2和EGFR作为我们的主要靶分子。在两种类型的口腔癌细胞OECM1和Cal27中评估了靶向复合物。 OECM1细胞系过表达Her2,但EGFR表达低,而Cal27细胞系表达两种抗体。此外,通过使用混合纳米探针,可以进一步提高针对OECM1的靶向功效。通过皮下注射在小鼠的背部诱导癌细胞。捕获的图像显示,这两种癌细胞都比具有特定靶向的对照组表现出更高的光声响应(最大3 dB),因此证明了使用生物共轭金纳米棒进行多重选择性靶向的可行性。使用OECM1细胞的混合纳米探针进行多次靶向的图像也显示了靶向的进一步增强(4 dB)。结果显示了体内光声分子成像的潜力,为癌症的诊断和治疗提供了更好的指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号